6 studies found for:    GLPG0634 | Phase 2, 3
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: GLPG0634;   Drug: Placebo
2 Recruiting Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Patients (DARWIN1)
Condition: Rheumatoid Arthritis
Interventions: Drug: GLPG0634;   Drug: Placebo
3 Recruiting Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Patients (DARWIN2)
Condition: Rheumatoid Arthritis
Interventions: Drug: GLPG0634;   Drug: Placebo
4 Completed Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Interventions: Drug: GLPG0634;   Drug: Placebo
5 Enrolling by invitation Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Drug: GLPG0634
6 Completed Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Drug: GLPG0634

Indicates status has not been verified in more than two years